{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T10:32:49Z","timestamp":1790937169388,"version":"4.1.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Discov"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although artemisinin combination therapies have succeeded in reducing the global burden of malaria, multidrug resistance of the deadliest malaria parasite, <jats:italic>Plasmodium falciparum<\/jats:italic>, is emerging worldwide. Innovative antimalarial drugs that kill all life-cycle stages of malaria parasites are urgently needed. Here, we report the discovery of the compound JX21108 with broad antiplasmodial activity against multiple life-cycle stages of malaria parasites. JX21108 was developed from chemical optimization of quisinostat, a histone deacetylase inhibitor. We identified <jats:italic>P. falciparum<\/jats:italic> histone deacetylase 1 (PfHDAC1), an epigenetic regulator essential for parasite growth and invasion, as a molecular target of JX21108. <jats:italic>PfHDAC1<\/jats:italic> knockdown leads to the downregulation of essential parasite genes, which is highly consistent with the transcriptomic changes induced by JX21108 treatment. Collectively, our data support that PfHDAC1 is a potential drug target for overcoming multidrug resistance and that JX21108 treats malaria and blocks parasite transmission simultaneously.<\/jats:p>","DOI":"10.1038\/s41421-020-00215-4","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T12:18:50Z","timestamp":1607689130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["A novel multistage antiplasmodial inhibitor targeting Plasmodium falciparum histone deacetylase 1"],"prefix":"10.1038","volume":"6","author":[{"given":"Zhenghui","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazheng","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maoxin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachasak","family":"Boonhok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yicong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiping","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaming","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3681-5052","authenticated-orcid":false,"given":"Wenyue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7521-8798","authenticated-orcid":false,"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"key":"215_CR1","unstructured":"WHO. World Malaria Report 2019 (World Health Organization, 2019)."},{"key":"215_CR2","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","volume":"19","author":"MD Conrad","year":"2019","unstructured":"Conrad, M. D. & Rosenthal, P. J. Antimalarial drug resistance in Africa: the calm before the storm? Lancet Infect. Dis. 19, e338\u2013e351 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"215_CR3","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S1473-3099(19)30394-9","volume":"19","author":"D M\u00e9nard","year":"2019","unstructured":"M\u00e9nard, D. & Fidock, D. A. Accelerated evolution and spread of multidrug-resistant Plasmodium falciparum takes down the latest first-line antimalarial drug in southeast Asia. Lancet Infect. Dis. 19, 916\u2013917 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"215_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrmicro3138","volume":"11","author":"EL Flannery","year":"2013","unstructured":"Flannery, E. L., Chatterjee, A. K. & Winzeler, E. A. Antimalarial drug discovery\u2014approaches and progress towards new medicines. Nat. Rev. Microbiol. 11, 849\u2013862 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"215_CR5","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1179\/2047773215Y.0000000013","volume":"109","author":"B Campo","year":"2015","unstructured":"Campo, B., Vandal, O., Wesche, D. L. & Burrows, J. N. Killing the hypnozoite-drug discovery approaches to prevent relapse in Plasmodium vivax. Pathog. Glob. health 109, 107\u2013122 (2015).","journal-title":"Pathog. Glob. health"},{"key":"215_CR6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nature14412","volume":"520","author":"A Mbengue","year":"2015","unstructured":"Mbengue, A. et al. A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. Nature 520, 683\u2013687 (2015).","journal-title":"Nature"},{"key":"215_CR7","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey, F. et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature 505, 50\u201355 (2014).","journal-title":"Nature"},{"key":"215_CR8","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1126\/science.aaf8675","volume":"358","author":"P Pino","year":"2017","unstructured":"Pino, P. et al. A multistage antimalarial targets the plasmepsins IX and X essential for invasion and egress. Science 358, 522\u2013528 (2017).","journal-title":"Science"},{"key":"215_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nature14451","volume":"522","author":"B Baragana","year":"2015","unstructured":"Baragana, B. et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature 522, 315\u2013320 (2015).","journal-title":"Nature"},{"key":"215_CR10","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature19804","volume":"538","author":"N Kato","year":"2016","unstructured":"Kato, N. et al. Diversity-oriented synthesis yields novel multistage antimalarial inhibitors. Nature 538, 344\u2013349 (2016).","journal-title":"Nature"},{"key":"215_CR11","doi-asserted-by":"crossref","unstructured":"Liang, X. et al. Discovery of 6\u2032-chloro-N-methyl-5\u2032-(phenylsulfonamido)-[3,3\u2032-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium. Eur. J. Med. Chem. 188, 112012 (2020).","DOI":"10.1016\/j.ejmech.2019.112012"},{"key":"215_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2724-z","volume":"18","author":"EG Tse","year":"2019","unstructured":"Tse, E. G., Korsik, M. & Todd, M. H. The past, present and future of anti-malarial medicines. Malar. J. 18, 93 (2019).","journal-title":"Malar. J."},{"key":"215_CR13","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1146\/annurev.pharmtox.45.120403.095825","volume":"45","author":"DC Drummond","year":"2005","unstructured":"Drummond, D. C. et al. Clinical development of histone deacetylase inhibitors as anticancer agents. Annu. Rev. Pharmacol. Toxicol. 45, 495\u2013528 (2005).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"215_CR14","doi-asserted-by":"publisher","first-page":"a026831","DOI":"10.1101\/cshperspect.a026831","volume":"6","author":"Y Li","year":"2016","unstructured":"Li, Y. & Seto, E. HDACs and HDAC inhibitors in cancer development and therapy. Cold Spring Harb. Perspect. Med. 6, a026831 (2016).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"215_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/bfgp\/elt047","volume":"13","author":"MF Duffy","year":"2014","unstructured":"Duffy, M. F., Selvarajah, S. A., Josling, G. A. & Petter, M. Epigenetic regulation of the Plasmodium falciparum genome. Brief. Funct. Genomics 13, 203\u2013216 (2014).","journal-title":"Brief. Funct. Genomics"},{"key":"215_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.chom.2011.11.011","volume":"11","author":"JC Volz","year":"2012","unstructured":"Volz, J. C. et al. PfSET10, a Plasmodium falciparum methyltransferase, maintains the active var gene in a poised state during parasite division. Cell Host Microbe 11, 7\u201318 (2012).","journal-title":"Cell Host Microbe"},{"key":"215_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature12361","volume":"499","author":"L Jiang","year":"2013","unstructured":"Jiang, L. et al. PfSETvs methylation of histone H3K36 represses virulence genes in Plasmodium falciparum. Nature 499, 223\u2013227 (2013).","journal-title":"Nature"},{"key":"215_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.chom.2014.06.014","volume":"16","author":"BI Coleman","year":"2014","unstructured":"Coleman, B. I. et al. A Plasmodium falciparum histone deacetylase regulates antigenic variation and gametocyte conversion. Cell Host Microbe 16, 177\u2013186 (2014).","journal-title":"Cell Host Microbe"},{"key":"215_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/science.aap7847","volume":"360","author":"M Zhang","year":"2018","unstructured":"Zhang, M. et al. Uncovering the essential genes of the human malaria parasite Plasmodium falciparum by saturation mutagenesis. Science 360, eaap7847 (2018).","journal-title":"Science"},{"key":"215_CR20","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/icb.2011.97","volume":"90","author":"KT Andrews","year":"2012","unstructured":"Andrews, K. T., Haque, A. & Jones, M. K. HDAC inhibitors in parasitic diseases. Immunol. Cell Biol. 90, 66\u201377 (2012).","journal-title":"Immunol. Cell Biol."},{"key":"215_CR21","doi-asserted-by":"publisher","first-page":"4780","DOI":"10.1021\/acs.jmedchem.6b01595","volume":"60","author":"GS Hailu","year":"2017","unstructured":"Hailu, G. S. et al. Lysine deacetylase inhibitors in parasites: past, present, and future perspectives. J. Med. Chem. 60, 4780\u20134804 (2017).","journal-title":"J. Med. Chem."},{"key":"215_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/156802609788085313","volume":"9","author":"KT Andrews","year":"2009","unstructured":"Andrews, K. T., Tran, T. N., Wheatley, N. C. & Fairlie, D. P. Targeting histone deacetylase inhibitors for anti-malarial therapy. Curr. Top. Med. Chem. 9, 292\u2013308 (2009).","journal-title":"Curr. Top. Med. Chem."},{"key":"215_CR23","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1128\/AAC.00439-08","volume":"52","author":"GS Dow","year":"2008","unstructured":"Dow, G. S. et al. Antimalarial activity of phenylthiazolyl-bearing hydroxamate-based histone deacetylase inhibitors. Antimicrob. Agents Chemother. 52, 3467\u20133477 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"215_CR24","doi-asserted-by":"publisher","first-page":"3849","DOI":"10.1128\/AAC.00030-12","volume":"56","author":"SD Sumanadasa","year":"2012","unstructured":"Sumanadasa, S. D. et al. Antimalarial activity of the anticancer histone deacetylase inhibitor SB939. Antimicrob. Agents Chemother. 56, 3849\u20133856 (2012).","journal-title":"Antimicrob. Agents Chemother."},{"key":"215_CR25","doi-asserted-by":"publisher","first-page":"1600347","DOI":"10.1002\/ardp.201600347","volume":"350","author":"LA Alves Avelar","year":"2017","unstructured":"Alves Avelar, L. A. et al. Design and synthesis of novel anti-plasmodial histone deacetylase inhibitors containing an alkoxyamide connecting unit. Arch. Pharm. 350, 1600347 (2017).","journal-title":"Arch. Pharm."},{"key":"215_CR26","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ijpddr.2016.12.005","volume":"7","author":"MJ Chua","year":"2017","unstructured":"Chua, M. J. et al. Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.Int. J. Parasitol. Drugs Drug Resist. 7, 42\u201350 (2017).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"215_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.4155\/fmc-2016-0215","volume":"9","author":"R De Vreese","year":"2017","unstructured":"De Vreese, R., de Kock, C., Smith, P. J., Chibale, K. & D\u2019hooghe, M. Exploration of thiaheterocyclic hHDAC6 inhibitors as potential antiplasmodial agents. Future Med. Chem. 9, 357\u2013364 (2017).","journal-title":"Future Med. Chem."},{"key":"215_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.bmcl.2014.12.051","volume":"25","author":"G Giannini","year":"2015","unstructured":"Giannini, G., Battistuzzi, G. & Vignola, D. Hydroxamic acid based histone deacetylase inhibitors with confirmed activity against the malaria parasite. Bioorg. Med. Chem. Lett. 25, 459\u2013461 (2015).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"215_CR29","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1128\/AAC.00729-08","volume":"53","author":"S Agbor-Enoh","year":"2009","unstructured":"Agbor-Enoh, S., Seudieu, C., Davidson, E., Dritschilo, A. & Jung, M. Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice. Antimicrob. Agents Chemother. 53, 1727\u20131734 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"215_CR30","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1128\/AAC.00757-07","volume":"52","author":"KT Andrews","year":"2008","unstructured":"Andrews, K. T. et al. Potent antimalarial activity of histone deacetylase inhibitor analogues. Antimicrob. Agents Chemother. 52, 1454\u20131461 (2008).","journal-title":"Antimicrob. Agents Chemother."},{"key":"215_CR31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.ejmech.2014.05.050","volume":"82","author":"FK Hansen","year":"2014","unstructured":"Hansen, F. K. et al. Discovery of HDAC inhibitors with potent activity against multiple malaria parasite life cycle stages. Eur. J. Med Chem. 82, 204\u2013213 (2014).","journal-title":"Eur. J. Med Chem."},{"key":"215_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ejmech.2018.09.018","volume":"158","author":"D Diedrich","year":"2018","unstructured":"Diedrich, D. et al. One-pot, multi-component synthesis and structure-activity relationships of peptoid-based histone deacetylase (HDAC) inhibitors targeting malaria parasites. Eur. J. Med. Chem. 158, 801\u2013813 (2018).","journal-title":"Eur. J. Med. Chem."},{"key":"215_CR33","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/cmdc.201800808","volume":"14","author":"MKW Mackwitz","year":"2019","unstructured":"Mackwitz, M. K. W. et al. Structure-activity and structure-toxicity relationships of peptoid-based histone deacetylase inhibitors with dual-stage antiplasmodial activity. ChemMedChem 14, 912\u2013926 (2019).","journal-title":"ChemMedChem"},{"key":"215_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/cmdc.201300469","volume":"9","author":"FK Hansen","year":"2014","unstructured":"Hansen, F. K. et al. Synthesis, antimalarial properties, and SAR studies of alkoxyurea-based HDAC inhibitors. ChemMedChem 9, 665\u2013670 (2014).","journal-title":"ChemMedChem"},{"key":"215_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59298-4","volume":"10","author":"N Coetzee","year":"2020","unstructured":"Coetzee, N. et al. Epigenetic inhibitors target multiple stages of Plasmodium falciparum parasites. Sci. Rep. 10, 2355 (2020).","journal-title":"Sci. Rep."},{"key":"215_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000737","volume":"6","author":"BK Chaal","year":"2010","unstructured":"Chaal, B. K., Gupta, A. P., Wastuwidyaningtyas, B. D., Luah, Y. H. & Bozdech, Z. Histone deacetylases play a major role in the transcriptional regulation of the Plasmodium falciparum life cycle. PLoS Pathog. 6, e1000737 (2010).","journal-title":"PLoS Pathog."},{"key":"215_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031847","volume":"7","author":"KT Andrews","year":"2012","unstructured":"Andrews, K. T. et al. Comparative gene expression profiling of P. falciparum malaria parasites exposed to three different histone deacetylase inhibitors. PLoS ONE 7, e31847 (2012).","journal-title":"PLoS ONE"},{"key":"215_CR38","doi-asserted-by":"publisher","first-page":"e02523","DOI":"10.1128\/AAC.02523-19","volume":"64","author":"LN Vanheer","year":"2020","unstructured":"Vanheer, L. N., Zhang, H., Lin, G. & Kafsack, B. F. C. Activity of epigenetic inhibitors against Plasmodium falciparum asexual and sexual blood stages. Antimicrob. Agents Chemother. 64, e02523\u201319 (2020).","journal-title":"Antimicrob. Agents Chemother."},{"key":"215_CR39","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1038\/leu.2009.121","volume":"23","author":"S Deleu","year":"2009","unstructured":"Deleu, S. et al. The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models. Leukemia 23, 1894\u20131903 (2009).","journal-title":"Leukemia"},{"key":"215_CR40","first-page":"6841","volume":"15","author":"J Arts","year":"2009","unstructured":"Arts, J. et al. JNJ-26481585, a novel \u201csecond-generation\u201d oral histone deacetylase inhibitor, shows broad-spectrum preclinical antitumoral activity. Cancer Res. 15, 6841\u20136851 (2009).","journal-title":"Cancer Res."},{"key":"215_CR41","unstructured":"Jiang, L. & Huang, Z. Novel high-efficiency antimalarial drug, quisinostat. WIPO\/PCT, WO2017\/143964A1 (2017)."},{"key":"215_CR42","unstructured":"Moffat, D. F. C., Patel, S. R., Mazzei, F. A., Belfield, A. J. & Van Meurs, S. Histone deacetylase inhibitors. WIPO\/PCT, WO2006123121A1 (2006)."},{"key":"215_CR43","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","volume":"17","author":"B Witkowski","year":"2017","unstructured":"Witkowski, B. et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study. Lancet Infect. Dis. 17, 174\u2013183 (2017).","journal-title":"Lancet Infect. Dis."},{"key":"215_CR44","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/ng.528","volume":"42","author":"J Mu","year":"2010","unstructured":"Mu, J. et al. Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs. Nat. Genet. 42, 268\u2013271 (2010).","journal-title":"Nat. Genet."},{"key":"215_CR45","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.molbiopara.2005.09.007","volume":"145","author":"CJ Janse","year":"2006","unstructured":"Janse, C. J. et al. High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. Mol. Biochem. Parasitol. 145, 60\u201370 (2006).","journal-title":"Mol. Biochem. Parasitol."},{"key":"215_CR46","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.exppara.2008.05.003","volume":"120","author":"L Cui","year":"2008","unstructured":"Cui, L., Miao, J., Wang, J., Li, Q. & Cui, L. Plasmodium falciparum: development of a transgenic line for screening antimalarials using firefly luciferase as the reporter. Exp. Parasitol. 120, 80\u201387 (2008).","journal-title":"Exp. Parasitol."},{"key":"215_CR47","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1111\/febs.14376","volume":"285","author":"A Kanyal","year":"2018","unstructured":"Kanyal, A. et al. Genome-wide survey and phylogenetic analysis of histone acetyltransferases and histone deacetylases of Plasmodium falciparum. FEBS J. 285, 1767\u20131782 (2018).","journal-title":"FEBS J."},{"key":"215_CR48","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.1016\/j.bmcl.2010.03.091","volume":"20","author":"JC Bressi","year":"2010","unstructured":"Bressi, J. C. et al. Exploration of the HDAC2 foot pocket: synthesis and SAR of substituted N-(2-aminophenyl)benzamides. Bioorg. Med. Chem. Lett. 20, 3142\u20133145 (2010).","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"215_CR49","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1016\/j.str.2004.04.012","volume":"12","author":"JR Somoza","year":"2004","unstructured":"Somoza, J. R. et al. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases. Structure 12, 1325\u20131334 (2004).","journal-title":"Structure"},{"key":"215_CR50","doi-asserted-by":"publisher","first-page":"5254","DOI":"10.1016\/j.bmc.2008.03.005","volume":"16","author":"P Mukherjee","year":"2008","unstructured":"Mukherjee, P., Pradhan, A., Shah, F., Tekwani, B. L. & Avery, M. A. Structural insights into the Plasmodium falciparum histone deacetylase 1 (PfHDAC-1): a novel target for the development of antimalarial therapy. Bioorg. Med. Chem. 16, 5254\u20135265 (2008).","journal-title":"Bioorg. Med. Chem."},{"key":"215_CR51","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner, R. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J. Med. Chem. 47, 1739\u20131749 (2004).","journal-title":"J. Med. Chem."},{"key":"215_CR52","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nbt.2925","volume":"32","author":"M Ghorbal","year":"2014","unstructured":"Ghorbal, M. et al. Genome editing in the human malaria parasite Plasmodium falciparum using the CRISPR-Cas9 system. Nat. Biotechnol. 32, 819\u2013821 (2014).","journal-title":"Nat. Biotechnol."},{"key":"215_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073783","volume":"8","author":"P Prommana","year":"2013","unstructured":"Prommana, P. et al. Inducible knockdown of Plasmodium gene expression using the glmS ribozyme. PLoS ONE 8, e73783 (2013).","journal-title":"PLoS ONE"},{"key":"215_CR54","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1517\/13543784.14.12.1497","volume":"14","author":"PA Marks","year":"2005","unstructured":"Marks, P. A. & Dokmanovic, M. Histone deacetylase inhibitors: discovery and development as anticancer agents. Expert Opin. investigational drugs 14, 1497\u20131511 (2005).","journal-title":"Expert Opin. investigational drugs"},{"key":"215_CR55","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1053\/j.seminhematol.2007.11.007","volume":"45","author":"EA Griffiths","year":"2008","unstructured":"Griffiths, E. A. & Gore, S. D. DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes. Semin Hematol. 45, 23\u201330 (2008).","journal-title":"Semin Hematol."},{"key":"215_CR56","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.2174\/138161207781663064","volume":"13","author":"G Elaut","year":"2007","unstructured":"Elaut, G., Rogiers, V. & Vanhaecke, T. The pharmaceutical potential of histone deacetylase inhibitors. Curr. Pharm. Des. 13, 2584\u20132620 (2007).","journal-title":"Curr. Pharm. Des."},{"key":"215_CR57","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ijpddr.2015.05.004","volume":"5","author":"JA Engel","year":"2015","unstructured":"Engel, J. A. et al. Profiling the anti-protozoal activity of anti-cancer HDAC inhibitors against Plasmodium and Trypanosoma parasites. Int. J. Parasitol. Drugs Drug Resist. 5, 117\u2013126 (2015).","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"215_CR58","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.3390\/ijms16023915","volume":"16","author":"MA Elbadawi","year":"2015","unstructured":"Elbadawi, M. A., Awadalla, M. K., Hamid, M. M., Mohamed, M. A. & Awad, T. A. Valproic acid as a potential inhibitor of Plasmodium falciparum histone deacetylase 1 (PfHDAC1): an in silico approach. Int. J. Mol. Sci. 16, 3915\u20133931 (2015).","journal-title":"Int. J. Mol. Sci."},{"key":"215_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-24296-0","volume":"8","author":"RG Saraiva","year":"2018","unstructured":"Saraiva, R. G. et al. Chromobacterium spp. mediate their anti-Plasmodium activity through secretion of the histone deacetylase inhibitor romidepsin. Sci. Rep. 8, 6176 (2018).","journal-title":"Sci. Rep."},{"key":"215_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53912-w","volume":"9","author":"E Koehne","year":"2019","unstructured":"Koehne, E. et al. Histone deacetylase inhibitors with high in vitro activities against Plasmodium falciparum isolates collected from Gabonese children and adults. Sci. Rep. 9, 17336 (2019).","journal-title":"Sci. Rep."},{"key":"215_CR61","doi-asserted-by":"publisher","first-page":"111755","DOI":"10.1016\/j.ejmech.2019.111755","volume":"184","author":"U Soumyanarayanan","year":"2019","unstructured":"Soumyanarayanan, U. et al. Discovery of a potent histone deacetylase (HDAC) 3\/6 selective dual inhibitor. Eur. J. Med. Chem. 184, 111755 (2019).","journal-title":"Eur. J. Med. Chem."},{"key":"215_CR62","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1126\/science.781840","volume":"193","author":"W Trager","year":"1976","unstructured":"Trager, W. & Jensen, J. B. Human malaria parasites in continuous culture. Science 193, 673\u2013675 (1976).","journal-title":"Science"},{"key":"215_CR63","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.48.5.1803-1806.2004","volume":"48","author":"M Smilkstein","year":"2004","unstructured":"Smilkstein, M., Sriwilaijaroen, N., Kelly, J. X., Wilairat, P. & Riscoe, M. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Antimicrob. Agents Chemother. 48, 1803\u20131806 (2004).","journal-title":"Antimicrob. Agents Chemother."},{"key":"215_CR64","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1111\/j.1365-2958.2005.05014.x","volume":"59","author":"T Ishino","year":"2006","unstructured":"Ishino, T., Orito, Y., Chinzei, Y. & Yuda, M. A calcium-dependent protein kinase regulates Plasmodium ookinete access to the midgut epithelial cell. Mol. Microbiol. 59, 1175\u20131184 (2006).","journal-title":"Mol. Microbiol."},{"key":"215_CR65","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.3201\/eid2208.160004","volume":"22","author":"M Boulle","year":"2016","unstructured":"Boulle, M. et al. Artemisinin-resistant Plasmodium falciparum K13 mutant alleles, Thailand-Myanmar border. Emerg. Infect. Dis. 22, 1503\u20131505 (2016).","journal-title":"Emerg. Infect. Dis."},{"key":"215_CR66","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1084\/jem.160.5.1585","volume":"160","author":"SB Aley","year":"1984","unstructured":"Aley, S. B., Sherwood, J. A. & Howard, R. J. Knob-positive and knob-negative Plasmodium falciparum differ in expression of a strain-specific malarial antigen on the surface of infected erythrocytes. J. Exp. Med. 160, 1585\u20131590 (1984).","journal-title":"J. Exp. Med."},{"key":"215_CR67","first-page":"57","volume":"21","author":"D Walliker","year":"1993","unstructured":"Walliker, D. & Beale, G. Synchronization and cloning of malaria parasites. Methods Mol. Biol. 21, 57\u201366 (1993).","journal-title":"Methods Mol. Biol."},{"key":"215_CR68","doi-asserted-by":"publisher","first-page":"177ra137","DOI":"10.1126\/scitranslmed.3005029","volume":"5","author":"A Nilsen","year":"2013","unstructured":"Nilsen, A. et al. Quinolone-3-diarylethers: a new class of antimalarial drug. Sci. Transl. Med. 5, 177ra137 (2013).","journal-title":"Sci. Transl. Med."},{"key":"215_CR69","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/AAC.00793-12","volume":"57","author":"AN Lacrue","year":"2013","unstructured":"Lacrue, A. N. et al. 4(1H)-quinolones with liver stage activity against Plasmodium berghei. Antimicrob. Agents Chemother. 57, 417\u2013424 (2013).","journal-title":"Antimicrob. Agents Chemother."},{"key":"215_CR70","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1073\/pnas.1813542116","volume":"116","author":"B Xiao","year":"2019","unstructured":"Xiao, B. et al. Epigenetic editing by CRISPR\/dCas9 in Plasmodium falciparum. Proc. Natl Acad. Sci. USA 116, 255\u2013260 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"215_CR71","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim, D., Langmead, B. & Salzberg, S. L. HISAT: a fast spliced aligner with low memory requirements. Nat. Methods 12, 357\u2013360 (2015).","journal-title":"Nat. Methods"},{"key":"215_CR72","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290\u2013295 (2015).","journal-title":"Nat. Biotechnol."},{"key":"215_CR73","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1093\/bioinformatics\/bts515","volume":"28","author":"J Feng","year":"2012","unstructured":"Feng, J. et al. GFOLD: a generalized fold change for ranking differentially expressed genes from RNA-seq data. Bioinformatics 28, 2782\u20132788 (2012).","journal-title":"Bioinformatics"},{"key":"215_CR74","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1467-985X.2010.00676_9.x","volume":"174","author":"C Ginestet","year":"2011","unstructured":"Ginestet, C. Ggplot2: elegant graphics for data analysis. J. R. Stat. Soc. 174, 245\u2013246 (2011).","journal-title":"J. R. Stat. Soc."}],"container-title":["Cell Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41421-020-00215-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-020-00215-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41421-020-00215-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T16:14:46Z","timestamp":1670256886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41421-020-00215-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["215"],"URL":"https:\/\/doi.org\/10.1038\/s41421-020-00215-4","relation":{},"ISSN":["2056-5968"],"issn-type":[{"value":"2056-5968","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,11]]},"assertion":[{"value":"24 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"93"}}